Workflow
Vertex Pharma Dips Despite Quarterly Beat And Slight Guidance Book
Investors·2025-11-04 05:12

More to follow. Follow Allison Gatlin on X/Twitter at @AGatlin_IBD. YOU MAY ALSO LIKE: TESLA WATCH: Elon Musk Pay Deal In Focus Vertex stock dipped late Monday after the biotech company reported adjusted earnings of 4.80pershareon4.80 per share on 3.08 billion in third-quarter sales. On average, analysts polled by FactSet expected Vertex Pharmaceuticals (VRTX) to earn 4.58ashareandreport4.58 a share and report 3.06 billion in sales. In the year-earlier period, Vertex earned 4.38ashareon4.38 a share on 2.77 billion in sales. The biotech giant rai ...